Vasopressin and metabolic disorders: translation from experimental models to clinical use

Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes

(2016) Gilberto Velho et al.   DIABETES CARE

Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community

(2016) Ronan Roussel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study

(2015) Ronan Roussel et al.   AMERICAN JOURNAL OF NEPHROLOGY

Increasing Water Intake in Chronic Kidney Disease: Why? Safe? Possible?

(2015) William F. Clark et al.   ANNALS OF NUTRITION AND METABOLISM

Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats

(2015) Christopher Taveau et al.   DIABETOLOGIA

Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus

(2015) Sofia Enhörning et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Multiple aberrant hormone receptors in Cushing's syndrome

(2015) Nada El Ghorayeb et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men

(2015) S. Goya Wannamethee et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial

(2015) Jessica M Sontrop et al.   BMJ Open

Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study

(2014) Cornelia Then et al.   ACTA DIABETOLOGICA

Comparison Between Copeptin and Vasopressin in a Population From the Community and in People With Chronic Kidney Disease

(2014) Ronan Roussel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria

(2013) G. Velho et al.   DIABETES CARE

Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

(2012) A. Abbasi et al.   DIABETOLOGIA

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

(2012) S Enhörning et al.   INTERNATIONAL JOURNAL OF OBESITY

Enhanced glucose tolerance in the Brattleboro rat

(2011) Kazuaki Nakamura et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Low Water Intake and Risk for New-Onset Hyperglycemia

(2011) R. Roussel et al.   DIABETES CARE

Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome

(2011) Sofia Enhörning et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Copeptin and the Risk of Diabetes Mellitus

(2010) Sofia Enhörning et al.   CIRCULATION

Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome

(2010) J W B de Groot et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Both V1A and V1B vasopressin receptors deficiency result in impaired glucose tolerance

(2009) Kazuaki Nakamura et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Plasma Carboxy-Terminal Provasopressin (Copeptin): A Novel Marker of Insulin Resistance and Metabolic Syndrome

(2009) Umer Saleem et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Relation between human vasopressin 1a gene variance, fat intake, and diabetes

(2008) Sofia Enhörning et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Gender and renal function influence plasma levels of copeptin in healthy individuals

(2008) Sanjay S. Bhandari et al.   CLINICAL SCIENCE